Tumor News and Research

RSS

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

The most aggressive variant of brain tumor - glioblastoma - has an average survival rate of 15 months. There is therefore an urgent need for new treatment strategies for this group of patients.

16 Aug 2017

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

16 Aug 2017

Research suggests novel approach to treating deadly pancreatic cancer

Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent.

16 Aug 2017

Researchers develop and validate new assay that detects gene fusions in solid tumors

An assay that identifies a peculiar but important abnormality in cancer cells has been developed and validated by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

14 Aug 2017

Study shows how breast cancer cells spread late in disease development

Breast cancer cells that spread to other parts of the body break off and leave the primary tumor at late stages of disease development, scientists from the Wellcome Trust Sanger Institute and their collaborators have found.

14 Aug 2017

Study provides promising framework to anticipate drug resistance in cancer

Being able to predict the resistance or sensitivity of a tumor cell to a drug is a key success-factor of cancer precision therapy.

14 Aug 2017

Researchers create anti-cancer drugs that can effectively kill 58 types of tumors

Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.

14 Aug 2017

Study: Liver inflammation increases cholesterol levels in people with diabetes

Inflammatory processes in the liver lead to elevated cholesterol levels in people with diabetes, thus promoting subsequent vascular diseases. This is the result of a study by scientists of Helmholtz Zentrum München, Technische Universität München and the Collaborative Research Center SFB 1118 at Heidelberg University Hospital.

14 Aug 2017

Complex sugar molecules could help in early detection of tumors

Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner.

14 Aug 2017

Highly sensitive blood test holds potential for quickly tracking cancer growth and spread

Stanford University scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA released from cancer cells into the blood.

14 Aug 2017

Better analysis of kidney tumor samples

Every year, just over 1000 people are diagnosed with kidney cancer in Sweden. The three most common variants are clear cell, papillary and chromophobe renal cancer.

11 Aug 2017

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

Fred Hutchinson Cancer Research Center is launching a new integrated research center to prevent and find cures for cancers caused by infectious agents.

10 Aug 2017

New guidelines may lead to better management of patients with glioma

A University of Portsmouth academic has helped to develop European guidelines to treat brain tumors more effectively.

10 Aug 2017

Study reveals strong prognostic indicators of survival in resected pancreatic cancer

A new study of patients who underwent curative surgical removal of a pancreatic ductal adenocarcinoma showed that two of the nine preoperative factors analyzed were strongly predictive of poor prognosis regardless of the tumor stage.

10 Aug 2017

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Moffitt Cancer Center and Cvergenx announced a new research partnership that aims to revolutionize radiation therapy. The goal of the Future of Radiation Therapy project is to create a framework for using a patient's genetic information to provide a personalized radiation treatment plan.

9 Aug 2017

Tumor News and Research

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Research suggests novel approach to treating deadly pancreatic cancer

Researchers develop and validate new assay that detects gene fusions in solid tumors

Study shows how breast cancer cells spread late in disease development

Study provides promising framework to anticipate drug resistance in cancer

Researchers create anti-cancer drugs that can effectively kill 58 types of tumors

Study: Liver inflammation increases cholesterol levels in people with diabetes

Complex sugar molecules could help in early detection of tumors

Highly sensitive blood test holds potential for quickly tracking cancer growth and spread

Better analysis of kidney tumor samples

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

New guidelines may lead to better management of patients with glioma

Study reveals strong prognostic indicators of survival in resected pancreatic cancer

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Researchers identify new regulators of brain metastases in lung cancer patients

Scientists identify 'killer peptide' released by diverse therapy-sensitive cancer cells

LSU Health New Orleans receives $15 million CDC grant for cancer control in Louisiana

Potential drug offers hope for therapy-resistant breast cancer patients

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News